Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Anti-Sence and Anti-Gene
1.2.3 Short Inhibitory Sequences
1.2.4 Gene Transfer Therapy
1.2.5 Nucleoside Analogs
1.2.6 Ribozymes
1.2.7 Aptamers
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Academic and Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Based Gene Therapy Market Perspective (2018-2029)
2.2 Global Nucleic Acid Based Gene Therapy Growth Trends by Region
2.2.1 Nucleic Acid Based Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nucleic Acid Based Gene Therapy Historic Market Size by Region (2018-2024)
2.2.3 Nucleic Acid Based Gene Therapy Forecasted Market Size by Region (2024-2029)
2.3 Nucleic Acid Based Gene Therapy Market Dynamics
2.3.1 Nucleic Acid Based Gene Therapy Industry Trends
2.3.2 Nucleic Acid Based Gene Therapy Market Drivers
2.3.3 Nucleic Acid Based Gene Therapy Market Challenges
2.3.4 Nucleic Acid Based Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nucleic Acid Based Gene Therapy by Players
3.1.1 Global Nucleic Acid Based Gene Therapy Revenue by Players (2018-2024)
3.1.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nucleic Acid Based Gene Therapy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Nucleic Acid Based Gene Therapy Market Concentration Ratio
3.4.1 Global Nucleic Acid Based Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Based Gene Therapy Revenue in 2022
3.5 Global Key Players of Nucleic Acid Based Gene Therapy Head office and Area Served
3.6 Global Key Players of Nucleic Acid Based Gene Therapy, Product and Application
3.7 Global Key Players of Nucleic Acid Based Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Based Gene Therapy Breakdown Data by Type
4.1 Global Nucleic Acid Based Gene Therapy Historic Market Size by Type (2018-2024)
4.2 Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Type (2024-2029)
5 Nucleic Acid Based Gene Therapy Breakdown Data by Application
5.1 Global Nucleic Acid Based Gene Therapy Historic Market Size by Application (2018-2024)
5.2 Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nucleic Acid Based Gene Therapy Market Size (2018-2029)
6.2 North America Nucleic Acid Based Gene Therapy Market Size by Type
6.2.1 North America Nucleic Acid Based Gene Therapy Market Size by Type (2018-2024)
6.2.2 North America Nucleic Acid Based Gene Therapy Market Size by Type (2024-2029)
6.2.3 North America Nucleic Acid Based Gene Therapy Market Share by Type (2018-2029)
6.3 North America Nucleic Acid Based Gene Therapy Market Size by Application
6.3.1 North America Nucleic Acid Based Gene Therapy Market Size by Application (2018-2024)
6.3.2 North America Nucleic Acid Based Gene Therapy Market Size by Application (2024-2029)
6.3.3 North America Nucleic Acid Based Gene Therapy Market Share by Application (2018-2029)
6.4 North America Nucleic Acid Based Gene Therapy Market Size by Country
6.4.1 North America Nucleic Acid Based Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Nucleic Acid Based Gene Therapy Market Size by Country (2018-2024)
6.4.3 North America Nucleic Acid Based Gene Therapy Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Nucleic Acid Based Gene Therapy Market Size (2018-2029)
7.2 Europe Nucleic Acid Based Gene Therapy Market Size by Type
7.2.1 Europe Nucleic Acid Based Gene Therapy Market Size by Type (2018-2024)
7.2.2 Europe Nucleic Acid Based Gene Therapy Market Size by Type (2024-2029)
7.2.3 Europe Nucleic Acid Based Gene Therapy Market Share by Type (2018-2029)
7.3 Europe Nucleic Acid Based Gene Therapy Market Size by Application
7.3.1 Europe Nucleic Acid Based Gene Therapy Market Size by Application (2018-2024)
7.3.2 Europe Nucleic Acid Based Gene Therapy Market Size by Application (2024-2029)
7.3.3 Europe Nucleic Acid Based Gene Therapy Market Share by Application (2018-2029)
7.4 Europe Nucleic Acid Based Gene Therapy Market Size by Country
7.4.1 Europe Nucleic Acid Based Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Nucleic Acid Based Gene Therapy Market Size by Country (2018-2024)
7.4.3 Europe Nucleic Acid Based Gene Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Nucleic Acid Based Gene Therapy Market Size (2018-2029)
8.2 China Nucleic Acid Based Gene Therapy Market Size by Type
8.2.1 China Nucleic Acid Based Gene Therapy Market Size by Type (2018-2024)
8.2.2 China Nucleic Acid Based Gene Therapy Market Size by Type (2024-2029)
8.2.3 China Nucleic Acid Based Gene Therapy Market Share by Type (2018-2029)
8.3 China Nucleic Acid Based Gene Therapy Market Size by Application
8.3.1 China Nucleic Acid Based Gene Therapy Market Size by Application (2018-2024)
8.3.2 China Nucleic Acid Based Gene Therapy Market Size by Application (2024-2029)
8.3.3 China Nucleic Acid Based Gene Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Nucleic Acid Based Gene Therapy Market Size (2018-2029)
9.2 Asia Nucleic Acid Based Gene Therapy Market Size by Type
9.2.1 Asia Nucleic Acid Based Gene Therapy Market Size by Type (2018-2024)
9.2.2 Asia Nucleic Acid Based Gene Therapy Market Size by Type (2024-2029)
9.2.3 Asia Nucleic Acid Based Gene Therapy Market Share by Type (2018-2029)
9.3 Asia Nucleic Acid Based Gene Therapy Market Size by Application
9.3.1 Asia Nucleic Acid Based Gene Therapy Market Size by Application (2018-2024)
9.3.2 Asia Nucleic Acid Based Gene Therapy Market Size by Application (2024-2029)
9.3.3 Asia Nucleic Acid Based Gene Therapy Market Share by Application (2018-2029)
9.4 Asia Nucleic Acid Based Gene Therapy Market Size by Region
9.4.1 Asia Nucleic Acid Based Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Nucleic Acid Based Gene Therapy Market Size by Region (2018-2024)
9.4.3 Asia Nucleic Acid Based Gene Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Details
11.1.2 Wave Life Sciences Business Overview
11.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Introduction
11.1.4 Wave Life Sciences Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.1.5 Wave Life Sciences Recent Developments
11.2 Imugene
11.2.1 Imugene Company Details
11.2.2 Imugene Business Overview
11.2.3 Imugene Nucleic Acid Based Gene Therapy Introduction
11.2.4 Imugene Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.2.5 Imugene Recent Developments
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Details
11.3.2 Sarepta Therapeutics Business Overview
11.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Introduction
11.3.4 Sarepta Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.3.5 Sarepta Therapeutics Recent Developments
11.4 Alnylam Pharmaceuticals
11.4.1 Alnylam Pharmaceuticals Company Details
11.4.2 Alnylam Pharmaceuticals Business Overview
11.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Introduction
11.4.4 Alnylam Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.4.5 Alnylam Pharmaceuticals Recent Developments
11.5 Ionis Pharmaceuticals
11.5.1 Ionis Pharmaceuticals Company Details
11.5.2 Ionis Pharmaceuticals Business Overview
11.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Introduction
11.5.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.5.5 Ionis Pharmaceuticals Recent Developments
11.6 Moderna
11.6.1 Moderna Company Details
11.6.2 Moderna Business Overview
11.6.3 Moderna Nucleic Acid Based Gene Therapy Introduction
11.6.4 Moderna Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.6.5 Moderna Recent Developments
11.7 BioNTech
11.7.1 BioNTech Company Details
11.7.2 BioNTech Business Overview
11.7.3 BioNTech Nucleic Acid Based Gene Therapy Introduction
11.7.4 BioNTech Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.7.5 BioNTech Recent Developments
11.8 Nutcracker Therapeutics
11.8.1 Nutcracker Therapeutics Company Details
11.8.2 Nutcracker Therapeutics Business Overview
11.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Introduction
11.8.4 Nutcracker Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.8.5 Nutcracker Therapeutics Recent Developments
11.9 Deep Genomics
11.9.1 Deep Genomics Company Details
11.9.2 Deep Genomics Business Overview
11.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Introduction
11.9.4 Deep Genomics Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.9.5 Deep Genomics Recent Developments
11.10 Sirnaomics
11.10.1 Sirnaomics Company Details
11.10.2 Sirnaomics Business Overview
11.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Introduction
11.10.4 Sirnaomics Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.10.5 Sirnaomics Recent Developments
11.11 Laronde
11.11.1 Laronde Company Details
11.11.2 Laronde Business Overview
11.11.3 Laronde Nucleic Acid Based Gene Therapy Introduction
11.11.4 Laronde Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.11.5 Laronde Recent Developments
11.12 Abogen Biosciences
11.12.1 Abogen Biosciences Company Details
11.12.2 Abogen Biosciences Business Overview
11.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Introduction
11.12.4 Abogen Biosciences Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024)
11.12.5 Abogen Biosciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Anti-Sence and Anti-Gene
Table 3. Key Players of Short Inhibitory Sequences
Table 4. Key Players of Gene Transfer Therapy
Table 5. Key Players of Nucleoside Analogs
Table 6. Key Players of Ribozymes
Table 7. Key Players of Aptamers
Table 8. Key Players of Others
Table 9. Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 10. Global Nucleic Acid Based Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Nucleic Acid Based Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 12. Global Nucleic Acid Based Gene Therapy Market Share by Region (2018-2024)
Table 13. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Nucleic Acid Based Gene Therapy Market Share by Region (2024-2029)
Table 15. Nucleic Acid Based Gene Therapy Market Trends
Table 16. Nucleic Acid Based Gene Therapy Market Drivers
Table 17. Nucleic Acid Based Gene Therapy Market Challenges
Table 18. Nucleic Acid Based Gene Therapy Market Restraints
Table 19. Global Nucleic Acid Based Gene Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 20. Global Nucleic Acid Based Gene Therapy Revenue Share by Players (2018-2024)
Table 21. Global Top Nucleic Acid Based Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Based Gene Therapy as of 2022)
Table 22. Global Nucleic Acid Based Gene Therapy Industry Ranking 2021 VS 2022 VS 2024
Table 23. Global 5 Largest Players Market Share by Nucleic Acid Based Gene Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 24. Global Key Players of Nucleic Acid Based Gene Therapy, Headquarters and Area Served
Table 25. Global Key Players of Nucleic Acid Based Gene Therapy, Product and Application
Table 26. Global Key Players of Nucleic Acid Based Gene Therapy, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nucleic Acid Based Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 29. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Type (2018-2024)
Table 30. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Type (2024-2029)
Table 32. Global Nucleic Acid Based Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 33. Global Nucleic Acid Based Gene Therapy Revenue Share by Application (2018-2024)
Table 34. Global Nucleic Acid Based Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Nucleic Acid Based Gene Therapy Revenue Share by Application (2024-2029)
Table 36. North America Nucleic Acid Based Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 37. North America Nucleic Acid Based Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 38. North America Nucleic Acid Based Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 39. North America Nucleic Acid Based Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 40. North America Nucleic Acid Based Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. North America Nucleic Acid Based Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 42. North America Nucleic Acid Based Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Europe Nucleic Acid Based Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 44. Europe Nucleic Acid Based Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 45. Europe Nucleic Acid Based Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 46. Europe Nucleic Acid Based Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 47. Europe Nucleic Acid Based Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Europe Nucleic Acid Based Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 49. Europe Nucleic Acid Based Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 50. China Nucleic Acid Based Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 51. China Nucleic Acid Based Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 52. China Nucleic Acid Based Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 53. China Nucleic Acid Based Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Nucleic Acid Based Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 55. Asia Nucleic Acid Based Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 56. Asia Nucleic Acid Based Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 57. Asia Nucleic Acid Based Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 58. Asia Nucleic Acid Based Gene Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia Nucleic Acid Based Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 60. Asia Nucleic Acid Based Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 68. Wave Life Sciences Company Details
Table 69. Wave Life Sciences Business Overview
Table 70. Wave Life Sciences Nucleic Acid Based Gene Therapy Product
Table 71. Wave Life Sciences Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 72. Wave Life Sciences Recent Developments
Table 73. Imugene Company Details
Table 74. Imugene Business Overview
Table 75. Imugene Nucleic Acid Based Gene Therapy Product
Table 76. Imugene Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 77. Imugene Recent Developments
Table 78. Sarepta Therapeutics Company Details
Table 79. Sarepta Therapeutics Business Overview
Table 80. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product
Table 81. Sarepta Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 82. Sarepta Therapeutics Recent Developments
Table 83. Alnylam Pharmaceuticals Company Details
Table 84. Alnylam Pharmaceuticals Business Overview
Table 85. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product
Table 86. Alnylam Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 87. Alnylam Pharmaceuticals Recent Developments
Table 88. Ionis Pharmaceuticals Company Details
Table 89. Ionis Pharmaceuticals Business Overview
Table 90. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product
Table 91. Ionis Pharmaceuticals Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 92. Ionis Pharmaceuticals Recent Developments
Table 93. Moderna Company Details
Table 94. Moderna Business Overview
Table 95. Moderna Nucleic Acid Based Gene Therapy Product
Table 96. Moderna Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 97. Moderna Recent Developments
Table 98. BioNTech Company Details
Table 99. BioNTech Business Overview
Table 100. BioNTech Nucleic Acid Based Gene Therapy Product
Table 101. BioNTech Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 102. BioNTech Recent Developments
Table 103. Nutcracker Therapeutics Company Details
Table 104. Nutcracker Therapeutics Business Overview
Table 105. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product
Table 106. Nutcracker Therapeutics Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 107. Nutcracker Therapeutics Recent Developments
Table 108. Deep Genomics Company Details
Table 109. Deep Genomics Business Overview
Table 110. Deep Genomics Nucleic Acid Based Gene Therapy Product
Table 111. Deep Genomics Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 112. Deep Genomics Recent Developments
Table 113. Sirnaomics Company Details
Table 114. Sirnaomics Business Overview
Table 115. Sirnaomics Nucleic Acid Based Gene Therapy Product
Table 116. Sirnaomics Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 117. Sirnaomics Recent Developments
Table 118. Laronde Company Details
Table 119. Laronde Business Overview
Table 120. Laronde Nucleic Acid Based Gene Therapy Product
Table 121. Laronde Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 122. Laronde Recent Developments
Table 123. Abogen Biosciences Company Details
Table 124. Abogen Biosciences Business Overview
Table 125. Abogen Biosciences Nucleic Acid Based Gene Therapy Product
Table 126. Abogen Biosciences Revenue in Nucleic Acid Based Gene Therapy Business (2018-2024) & (US$ Million)
Table 127. Abogen Biosciences Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Nucleic Acid Based Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Anti-Sence and Anti-Gene Features
Figure 4. Short Inhibitory Sequences Features
Figure 5. Gene Transfer Therapy Features
Figure 6. Nucleoside Analogs Features
Figure 7. Ribozymes Features
Figure 8. Aptamers Features
Figure 9. Others Features
Figure 10. Global Nucleic Acid Based Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Nucleic Acid Based Gene Therapy Market Share by Application: 2022 VS 2029
Figure 12. Hospitals and Clinics Case Studies
Figure 13. Academic and Research Institutes Case Studies
Figure 14. Others Case Studies
Figure 15. Nucleic Acid Based Gene Therapy Report Years Considered
Figure 16. Global Nucleic Acid Based Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Nucleic Acid Based Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Nucleic Acid Based Gene Therapy Market Share by Region: 2022 VS 2029
Figure 19. Global Nucleic Acid Based Gene Therapy Market Share by Players in 2022
Figure 20. Global Top Nucleic Acid Based Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Based Gene Therapy as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Nucleic Acid Based Gene Therapy Revenue in 2022
Figure 22. North America Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Nucleic Acid Based Gene Therapy Market Share by Type (2018-2029)
Figure 24. North America Nucleic Acid Based Gene Therapy Market Share by Application (2018-2029)
Figure 25. North America Nucleic Acid Based Gene Therapy Market Share by Country (2018-2029)
Figure 26. United States Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Nucleic Acid Based Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 29. Europe Nucleic Acid Based Gene Therapy Market Share by Type (2018-2029)
Figure 30. Europe Nucleic Acid Based Gene Therapy Market Share by Application (2018-2029)
Figure 31. Europe Nucleic Acid Based Gene Therapy Market Share by Country (2018-2029)
Figure 32. Germany Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. France Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. U.K. Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Italy Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Russia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Nordic Countries Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. China Nucleic Acid Based Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 39. China Nucleic Acid Based Gene Therapy Market Share by Type (2018-2029)
Figure 40. China Nucleic Acid Based Gene Therapy Market Share by Application (2018-2029)
Figure 41. Asia Nucleic Acid Based Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 42. Asia Nucleic Acid Based Gene Therapy Market Share by Type (2018-2029)
Figure 43. Asia Nucleic Acid Based Gene Therapy Market Share by Application (2018-2029)
Figure 44. Asia Nucleic Acid Based Gene Therapy Market Share by Region (2018-2029)
Figure 45. Japan Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. South Korea Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. China Taiwan Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Southeast Asia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. India Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Australia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Share by Type (2018-2029)
Figure 53. Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Share by Application (2018-2029)
Figure 54. Middle East, Africa, and Latin America Nucleic Acid Based Gene Therapy Market Share by Country (2018-2029)
Figure 55. Brazil Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Mexico Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Turkey Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Israel Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. GCC Countries Nucleic Acid Based Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. Wave Life Sciences Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 62. Imugene Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 63. Sarepta Therapeutics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 64. Alnylam Pharmaceuticals Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 65. Ionis Pharmaceuticals Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 66. Moderna Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 67. BioNTech Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 68. Nutcracker Therapeutics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 69. Deep Genomics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 70. Sirnaomics Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 71. Laronde Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 72. Abogen Biosciences Revenue Growth Rate in Nucleic Acid Based Gene Therapy Business (2018-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed